Biotech · Private company
Precision Biologics, Inc
Track this companyFree. Adds Precision Biologics, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- GemcitabinePhase 2 · Pancreatic Cancer, AdultClinicalTrials.gov · fetched Nov 12, 2026
- nab-paclitaxelPhase 2 · Pancreatic Cancer, AdultClinicalTrials.gov · fetched Nov 12, 2026
- NEO-201 in combination with pembrolizumabPhase 2 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- NPC-1CPhase 2 · Pancreatic Cancer, AdultClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Study of NEO-201 in Solid Tumors Expansion CohortsPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jan 18, 2019ClinicalTrials.gov NCT03476681 · fetched Nov 12, 2026
- QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic CancerPHASE1_PHASE2 · TERMINATED · started Apr 1, 2013ClinicalTrials.gov NCT01834235 · fetched Nov 12, 2026